Phase 4
This is a research study to test the tolerability and clinical effectiveness of the study drug, Letermovir (LET), when used as secondary prophylaxis following …
Cytomegalovirus InfectionsInfection in Solid Organ Transplant RecipientsNeutropenia+1 more